Search research articles
Contact Us
Filters
Showing results (81-90 of 161) with videos related to
Page
of 17
Sort By:
Journal of Translational Medicine
|
June 5, 2023
Group-specific cellular metabolism in Medulloblastoma
Viktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry
Jonas Ecker, Florian Selt, Dominik Sturm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2023
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]
Jonas Ecker, Florian Selt, Dominik Sturm, et al.
International Journal of Cancer
|
April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis
Umar Khalid, Milena Simovic, Linda A Hammann, et al.
Cancer Research
|
January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3
Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Acta Neuropathologica
|
December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
Alfa H C Bai, Till Milde, Marc Remke, et al.
Oncotarget
|
December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
Florian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Acta Neuropathologica
|
July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions
Damian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Orphanet Journal of Rare Diseases
|
May 5, 2019
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study
Afshin Saffari, Ines Brösse, Adelheid Wiemer-Kruel, et al.
Acta Neuropathologica
|
September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma
Daniel Picard, Jörg Felsberg, Maike Langini, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 161) with videos related to
Sort By:
Page
of 17
Journal of Translational Medicine
|
June 5, 2023
Group-specific cellular metabolism in Medulloblastoma
Viktoria L E Funke, Carolin Walter, Viktoria Melcher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry
Jonas Ecker, Florian Selt, Dominik Sturm, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 23, 2023
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]
Jonas Ecker, Florian Selt, Dominik Sturm, et al.
International Journal of Cancer
|
April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsis
Umar Khalid, Milena Simovic, Linda A Hammann, et al.
Cancer Research
|
January 15, 2014
GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3
Johannes Fabian, Marco Lodrini, Ina Oehme, et al.
Acta Neuropathologica
|
December 3, 2011
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
Alfa H C Bai, Till Milde, Marc Remke, et al.
Oncotarget
|
December 22, 2016
Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing
Florian Selt, Juliane Hohloch, Thomas Hielscher, et al.
Acta Neuropathologica
|
July 7, 2019
Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions
Damian Stichel, Daniel Schrimpf, Belén Casalini, et al.
Orphanet Journal of Rare Diseases
|
May 5, 2019
Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under 2 years of age - a multicenter retrospective study
Afshin Saffari, Ines Brösse, Adelheid Wiemer-Kruel, et al.
Acta Neuropathologica
|
September 1, 2023
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma
Daniel Picard, Jörg Felsberg, Maike Langini, et al.
Page
of 17